Managing complexity across biopharma modalities
Managing complexity across biopharma modalities is a pharma and life sciences industry update from FierceBiotech. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
SK pharmteco CEO Joerg Ahlgrimm discusses complexity, global pressure and drug development speed.
Source: FierceBiotech